Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nontuberculous mycobacteria.

S M Holland1

  • 1Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-1886, USA. smh@nih.gov

The American Journal of the Medical Sciences
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disseminated tuberculosis, CMV viraemia & haemophagocytic-lymphohistiocystosis syndrome in an adult patient with anti- IFNγ autoantibodies - case report and brief review.

Clinical immunology communications·2023
Same author

IL-10 signaling in dendritic cells controls IL-1β-mediated IFNγ secretion by human CD4<sup>+</sup> T cells: relevance to inflammatory bowel disease.

Mucosal immunology·2019
Same author

Monozygotic twins with GATA2 deficiency: same haploidentical-related donor, different severity of GvHD.

Bone marrow transplantation·2017
Same author

Nine patients with chronic granulomatous disease having selective neck dissection for severe cervical lymphadenitis.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2017
Same author

Correction: ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.

The Journal of experimental medicine·2017
Same author

ERBIN deficiency links STAT3 and TGF-β pathway defects with atopy in humans.

The Journal of experimental medicine·2017
Same journal

Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

The American journal of the medical sciences·2026
Same journal

In Memoriam: Maurice A. Mufson, MD, MACP.

The American journal of the medical sciences·2026
Same journal

Outcomes of acute myeloid leukemia patients admitted to the intensive care unit within 100 days of allogeneic hematopoietic stem cell transplantation.

The American journal of the medical sciences·2026
Same journal

Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

The American journal of the medical sciences·2026
Same journal

Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

The American journal of the medical sciences·2026
Same journal

The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

The American journal of the medical sciences·2026
See all related articles

Nontuberculous mycobacteria are common environmental microbes rarely causing human disease, indicating robust host defenses. Studying susceptible individuals can reveal resistance mechanisms against these and related pathogens like Mycobacterium tuberculosis (MTB).

Area of Science:

  • Microbiology
  • Immunology
  • Genetics

Background:

  • Nontuberculous mycobacteria (NTM) are ubiquitous environmental organisms.
  • Despite widespread exposure, NTM rarely cause disease in humans, suggesting strong host immunity.
  • Commonly encountered NTM species include Mycobacterium avium, M. intracellulare, M. kansasii, M. fortuitum, M. abscessus, and M. chelonae.

Purpose of the Study:

  • To investigate host defense mechanisms against NTM infections.
  • To identify genetic and acquired factors influencing susceptibility to NTM.
  • To leverage findings for understanding and treating Mycobacterium tuberculosis (MTB) infections.

Main Methods:

  • Study of patients with abnormal susceptibility to NTM infections.
  • Analysis of host defense mechanisms against environmental mycobacteria.

Related Experiment Videos

  • Identification of host factors enabling NTM infection in immunocompetent individuals.

    • Main Results:

    • Patients with NTM susceptibility may have identifiable immune defects.
    • Understanding NTM resistance mechanisms can inform MTB defense strategies.
    • Identifying susceptibility pathways can reveal therapeutic targets.

    Conclusions:

    • Research into NTM susceptibility aids in understanding MTB pathogenesis.
    • Discovering host factors for NTM infection offers therapeutic intervention opportunities.
    • Studying NTM provides insights into host defense against related mycobacterial pathogens.